News | December 10, 2013

Surgeon Astronaut Shares Experience of How Microgravity Effects the Body

December 10, 2013 — The human body begins to adapt to microgravity of low Earth orbit shortly after launch, according to surgeon astronaut Lee Morin, M.D., Ph.D., and astronaut mission specialist, NASA Johnson Space Center, Houston. Morin visited the International Space Station in 2002 as part of the STS-110 Atlantis space shuttle crew.
"Evolution has not prepared the human body for the space environment. However, the human body does successfully adapt to space,” said Morin at the 40th Annual VEITHsymposium. “These changes begin immediately upon exposure to microgravity, although understanding is confounded by the stresses during launch from the Earth's surface into low Earth orbit. The engineering and physics constraints of rocket science bracket the launch duration to furious eight or nine minutes. Immediately post-insertion, adaptation begins.”
Morin shared his experience in space, along with the effects of microgravity on the body's systems. According to Morin, fluid shifts immediately from the lower extremities to the upper part of the body and superficial veins in the neck become engorged. Within the first 15 minutes, up to two-thirds of astronauts suffer from motion sickness that can last up to seven days.
The cardiovascular system experiences a number of changes, including increased cardiac output; a 10 to 15 percent plasma volume loss begins immediately along with a 10 percent reduction in erythrocyte mass. 
"Fortunately, cardiovascular changes of space do not threaten survival,” said Morin. “There is no increase of arrhythmias in space.”
Changes to the musculoskeletal system develop with medium to long-term microgravity exposures. Skeletal muscle atrophies and strength is lost. Bone mineral density is also affected with a loss rate of about 1.5 percent per month from the weight bearing bones. 
"Over the past decade we have learned to control these losses with heavy resistive exercise on a daily basis," said Morin.
Radiation exposure is the most significant health threat in microgravity. Spacecraft can only be partially shielded from radiation. 
"Crew can sense radiation, they often report light flashes within their eyes, usually when eyes are closed pre-sleep," said Morin. 
The primary radiation risk to the crew is increased lifetime cancer mortality.
For more information:,

Related Content

BioCardia Announces 12-Month Results from TRIDENT Trial of Stem Cell Delivery System
News | Stem Cell Therapies| September 26, 2017
BioCardia Inc. recently announced 12-month results from the Phase II TRIDENT clinical trial, conducted by the...
News | Vena Cava Filters| September 26, 2017
September 26, 2017 — The one-year results of the SENTRY...
Treatment of Heart Attack Patients Depends on Cancer History
News | Cardio-oncology| September 26, 2017
Treatment of heart attack patients depends on their history of cancer, according to research published recently in...
CardiAMP Heart Failure Trial Design Presented at Texas Heart Institute Symposium
News | Heart Failure| September 25, 2017
BioCardia Inc. announced the trial design for its pivotal Phase III CardiAMP Heart Failure Trial was presented during...
Biotronik Studies Demonstrate Efficacy of Minimizing Metal Burden in SFA Therapy
News | Stents Bare Metal| September 22, 2017
Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy could effectively reduce...
Edwards Inspiris Resilia Valve Receives FDA Approval
News | Heart Valve Technology| September 21, 2017
Edwards Lifesciences Corp. recently received U.S. Food and Drug Administration (FDA) approval for its Inspiris Resilia...
MyoKardia Presents Additional Positive Data From Phase 2 PIONEER-HCM Study at HFSA 2017
News | Heart Failure| September 21, 2017
MyoKardia Inc. announced that additional positive data from the first patient cohort of its Phase 2 PIONEER-HCM study...
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Overlay Init